The decision to demerge the CSL Seqirus business into a separate ASX-listed company will allow it to "set an independent ...

Shares in Viking Therapeutics have lost more than 40% of their value after it reported phase 2 results that showed that its ...

Perhaps it’s just the summer slowdown, but it’s been a light month for executive hires in the pharma and biotech world.

According to Palo Alto, California-based Atropos, its researchers have already come up with an initial AI model that has ...

When it comes to GLP-1 drugs like Ozempic, Wegovy, and Mounjaro there’s a lot to talk about, from the science behind the ...

It is in the shadow of these changes that the 7th Cell Therapy Analytical Development Summit returns to unite the field.

Merck KGaA's recently acquired SpringWorks unit has claimed EU approval for Ogsiveo, becoming the first approved therapy for ...

Six digital health technologies (DHTs) that can help with the rehabilitation of people with cardiovascular disease have been ...

Synthetic data is emerging as a powerful solution to the ongoing challenge of balancing patient privacy with the need for ...

And while pharma marketing agencies are embracing AI like everyone else, most are using AI tools on a case-by-case basis to tackle one or more of those areas. But what if an agency were to redesign ...

Novo Nordisk has reduced the price of its two semaglutide-based therapies – Ozempic for diabetes and Wegovy for obesity – to ...

Washington DC-based Vanda was sent a complete response letter (CRL) from the FDA in 2019, rejecting Hetlioz (tasimelteon) for ...